NCT00770666View on ClinicalTrials.gov

Combination Medications vs. Patch Alone for Medically-Ill Smokers

PHASE4CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
Smoking Cessation
Interventions
DRUG

Nicotine patch, nicotine inhaler, bupropion

Patch - 21 mg - taper as able Inhaler - as needed Bupropion SR 150 mg daily

DRUG

Nicotine patch

21 mg daily for 6 weeks followed by 14 mg for 2 weeks and then 7 mg for 2 weeks

Trial Locations (1)

08903

Umdnj-Rwjms, New Brunswick

All Listed Sponsors
collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

Robert Wood Johnson Foundation

OTHER

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00770666 - Combination Medications vs. Patch Alone for Medically-Ill Smokers | Biotech Hunter | Biotech Hunter